Michael A. Klobuchar - 24 Feb 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP - Chief Strategy Officer
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Michael Klobuchar
Issuer symbol
MRK
Transactions as of
24 Feb 2022
Net transactions value
+$220,089
Form type
4
Filing time
28 Feb 2022, 15:22:01 UTC
Previous filing
15 Jul 2021
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $220,089 +2,994 +27% $73.51 14,059 24 Feb 2022 Direct F1, F2
holding MRK Common Stock 6 24 Feb 2022 By Child
holding MRK Common Stock 6 24 Feb 2022 By Child
holding MRK Common Stock - 401(k) Plan 817 24 Feb 2022 By 401(k) F3
holding MRK Common Stock - 401(k) Plan 658 24 Feb 2022 By Spouse F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through January 7, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.